Zobrazeno 1 - 10
of 691
pro vyhledávání: '"Kariagina AS"'
Publikováno v:
In Food and Chemical Toxicology April 2024 186
Autor:
S. S. Bessmeltsev, L. V. Stelmashenko, E. I. Podoltseva, E. V. Kariagina, G. N. Salogub, А. S. Nisamutdinova, L. M. Matuhina, K. M. Abdulkadyrov
Publikováno v:
Онкогематология, Vol 0, Iss 4, Pp 61-66 (2022)
Theproteasome inhibitor bortezomib (Velcade) has demonstrated clinical activity in patients with multiple myeloma (MM). We report the activity of borte-zomib plus dexamethasone in 60patients with relapsed and refractory myeloma. The patients had a me
Externí odkaz:
https://doaj.org/article/8553a7bdc296417c8a2e1b3fa806ced5
Autor:
S. S. Bessmeltsev, L. V. Stelmashenko, N. V. Stepanova, K. M. Abdulkadyrov, G. N. Salogub, E. R. Machulaitene, E. V. Kariagina
Publikováno v:
Онкогематология, Vol 0, Iss 2, Pp 40-45 (2022)
We used the bortezomib (velcade) plus MP (VMP) in 24 previously untreated patients with multiple myeloma (MM). The patients had a median age of 73 years (range, 65–83 years). For patients who received velcade plus MP the overall response rate was 6
Externí odkaz:
https://doaj.org/article/b683f210247445cdb987afa77e18fa09
Autor:
S. S. Bessmeltsev, L. V. Stelmashenko, E. V. Kariagina, N. V. Stepanova, G. N. Salogub, T. L. Shelkovskaya, T. A. Malakhova, I. A. Skorokhod, E. I. Podoltseva, N. O. Saraeva, O. I. Kovalev, A. V. Klimovich, N. V. Medvedeva, K. M. Abdulkadyrov, L. I. Krylova, T. H. Potrachkova, M. A. Novikova, E. R. Machulaitene, E. I. Darskaya, L. M. Matukhina, N. A. Kotova, O. Ya. Kostina, I. A. Novokreshchenova
Publikováno v:
Онкогематология, Vol 0, Iss 4, Pp 6-13 (2022)
We used the bortezomib plus dexamethasone (VD) and bortezomib plus MP (VMP) in 56 previously untreated elderly patients with multiple myeloma. The patients were 65–89 years old. For patients who received bortezomib plus MP the overall response rate
Externí odkaz:
https://doaj.org/article/c2efdc3ba2154cfb809d445aa9adf43d
Autor:
A. M. Chekalov, M. O. Popova, I. V. Tsygankov, Yu. A. Rogacheva, N. P. Volkov, K. V. Lepik, M. V. Demchenkova, T. V. Schneider, Yu. V. Kopeikina, N. V. Medvedeva, I. S. Zyuzgin, E. S. Pavlyuchenko, A. N. Levanov, A. A. Myasnikov, E. V. Kariagina, N. B. Mikhailova, V. V. Baykov, A. D. Kulagin
Publikováno v:
Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова, Vol 29, Iss 3, Pp 65-73 (2022)
Introduction. The risk of developing Hodgkin lymphoma (HL) with HIV infection is higher than in the general population, and the course of the disease itself is more aggressive. Currently, there is no unified approach to the treatment of HIV-related H
Externí odkaz:
https://doaj.org/article/ea9ed8309c9d4e90a602283379e9c436
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kariagina, Anastasia1 (AUTHOR), Doseff, Andrea I.2,3 (AUTHOR) doseffan@msu.edu
Publikováno v:
International Journal of Molecular Sciences. Dec2022, Vol. 23 Issue 24, p15753. 27p.
Autor:
E. Kleina, S. Voloshin, J. Vokueva, O. Petukhova, L. Martynenko, M. Bakai, J. Ruzhenkova, S. Linnikov, E. Kariagina, O. Uspenskaia, I. Ziuzgin, S. Bessmelcev, S. Sidorkevich, I. Martynkevich
Publikováno v:
HemaSphere, Vol 6, Pp 1003-1004 (2022)
Externí odkaz:
https://doaj.org/article/fcbd64f8c457416faa4761fd044cf7b3
Autor:
Mark D. Aupperlee, Anastasia Kariagina, Nicole Zaremba, Marc D. Basson, Richard C. Schwartz, Sandra Z. Haslam
Publikováno v:
Translational Oncology, Vol 11, Iss 2, Pp 518-527 (2018)
Increased proliferation and breast cancer risk has been observed in postmenopausal women receiving estrogen (E) + progestin hormone replacement therapy (HRT). Progestin action is mediated through two progesterone receptor (PR) isoforms, PRA and PRB,
Externí odkaz:
https://doaj.org/article/e3c8e6ddd35a4709a36330e621340507
Autor:
Kariagina, T.D., Ivanova, A.V.
Publikováno v:
Journal of Russian & East European Psychology. 2017, Vol. 54 Issue 6, p470-497. 28p. 3 Charts.